Long

GRTX important Price Target Upgrades Today !

An "error" in previously released results sent Galera Therapeutics, Inc. (GRTX) stock price down by more than 70% in October.

Today GRTX was upgraded today by HC Wainwright to buy, 10usd price target and by BTIG Research to 15usd price target.

Have you bought it yesterday?
buycancercancervaccineFundamental AnalysisgaleragaleratherapeuticsGRTXTechnical IndicatorssignalsignalsTrend Analysisupgrade

Also on:

Disclaimer